Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.28 | N/A |
| PEG Ratio (TTM) | -1.18 | N/A |
| P/S Ratio (TTM) | 2.57 | N/A |
| P/B Ratio (TTM) | 0.84 | N/A |
| P/FCF Ratio (TTM) | 29.46 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.63 | N/A |
| Price to 5YR AVG FCF Ratio | 9.51 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.78% | N/A |
| ROE (TTM) | 6.37% | N/A |
| Net Profit Margin (TTM) | 19.38% | N/A |
| ROIC 5YR AVG | -103.39% | N/A |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.14% | 1.36% | 7.93% |
| Revenue | -0.97% | 5.82% | 8.03% |
| Net Income | -8.68% | 12.30% | 14.65% |
| Cash Flow | 50.60% | 5.63% | 8.86% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1,044.53 | N/A |
| Quick Ratio (TTM) | 1,044.53 | N/A |
| D/E Ratio (TTM) | 0.06 | N/A |
| Interest Coverage (TTM) | 1.43 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.21 | N/A |
| LTL to 5YR AVG FCF | 0.65 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.52% | N/A |